glp 1 drug class What to Make of the GLP-1 Coverage and Cost Landscape GLP-1-based therapies for diabetes, obesity
Description
Tai J, Liu W, Li Y, Li L, Hlscher C

In an email to Global News, a spokesperson from Novo Nordisk said Druckers research provided the basis for understanding GLP-1 receptor agonists, to be developed as pharmacologic therapies for the treatment of Type 2 diabetes

Retatrutide produces GI side effects at roughly 1.5 to 2 times the rate of tirzepatide

Klebanoff, Ashwin K

Start with fluids and gentle movement
